Carson KV, Verbiest MEA, Crone MR, et al. Training health pro- fessionals in smoking cessation. Cochrane Database Syst Rev. 2012:CD000214. S4.5-2. Patnode CD, Henderson JT, Thompson JH, et al. Behavioral coun- seling and pharmacotherapy interventions for tobacco cessation in adults, including pregnant women: a review of reviews for the US Preventive Services Task Force. Ann Intern Med. 2015;163: 608 21. S4.5-3. Stead LF, Koilpillai P, Fanshawe TR1, et al. Combined pharmacother- apy and behavioural interventions for smoking cessation. Cochrane Database Syst Rev. 2016;3:CD008286. S4.5-4. Pan A, Wang Y, Talaei M, et al. Relation of smoking with total mortality and cardiovascular events among patients with diabe- tes mellitus: a meta-analysis and systematic review. Circulation. 2015;132:1795 804. S4.5-5. Mons U, M ezzinler A, Gellert C, et al. Impact of smoking and smok- ing cessation on cardiovascular events and mortality among older adults: meta-analysis of individual participant data from prospective cohort studies of the CHANCES consortium. BMJ. 2015;350:h1551. S4.5-6. Lv X, Sun J, Bi Y, et al. Risk of all-cause mortality and cardiovascular disease associated with secondhand smoke exposure: a systematic review and meta-analysis. Int J Cardiol. 2015;199:106 15. S4.5-7. US National Center for Chronic Disease Prevention and Health Promotion Office on Smoking and Health. The Health Consequences of Smoking 50 Years of Progress: A Report of the Surgeon General. 2014. US Centers for Disease Control and Prevention: Atlanta, GA. Available at: http://www.ncbi.nlm.nih.gov/books/NBK179276. Accessed January 5, 2019. S4.5-8. Teo KK, Ounpuu S, Hawken S, et al. Tobacco use and risk of myo- cardial infarction in 52 countries in the INTERHEART study: a case- control study. Lancet. 2006;368:647 58. S4.5-9. US Department of Health and Human Services. Healthy People 2020. Washington, DC: 2010. Available at: https://www.healthypeople. gov. Accessed January 3, 2019. S4.5-10. Bhatnagar A, Whitsel LP, Ribisl KM, et al. 